Cargando…

Relationship between nonalcoholic fatty liver disease and hyperandrogenemia in adolescents with polycystic ovary syndrome

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is common in adults with polycystic ovary syndrome (PCOS), and several studies on adults have investigated its influencing factors. However, factors associated with NAFLD in adolescents with PCOS remain unknown. PURPOSE: This study aimed to invest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kara, Ozlem, Arsoy, Hanife Aysegul, Keskin, Murat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Pediatric Society 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475859/ https://www.ncbi.nlm.nih.gov/pubmed/37321582 http://dx.doi.org/10.3345/cep.2023.00353

Ejemplares similares

Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications
por: López-Alarcón, Mardia, et al.
Publicado: (2023)

SAT-224 Polycystic Ovary Syndrome with Adrenal Hyperandrogenemia and Refractory Hirsutism
por: Parveen, Sanober, et al.
Publicado: (2019)

Metastatin as a Marker for Hyperandrogenemia in Iraqi Women with Polycystic Ovary Syndrome
por: Abdalqader, Manal Madany, et al.
Publicado: (2020)

Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
por: O'Reilly, Michael W., et al.
Publicado: (2014)

Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype
por: Lerchbaum, Elisabeth, et al.
Publicado: (2014)

Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome
por: Wang, Dongxu, et al.
Publicado: (2022)

SAT356 Predicting Nonalcoholic Fatty Liver Disease in Adolescent Girls with Polycystic Ovary Syndrome and Obesity
por: Lo, Jaclyn S, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease in a Sample of Iranian Women with Polycystic Ovary Syndrome
por: Mehrabian, Ferdous, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome: A Race Against the Clock
por: Huffman, Alexandra M, et al.
Publicado: (2022)

Embryos from polycystic ovary syndrome patients with hyperandrogenemia reach morula stage faster than controls
por: Chappell, Neil Ryan, et al.
Publicado: (2020)

Single-Cell RNA-Seq Identifies Pathways and Genes Contributing to the Hyperandrogenemia Associated with Polycystic Ovary Syndrome
por: Harris, R. Alan, et al.
Publicado: (2023)

Unraveling the Interplay between Nonalcoholic Fatty Liver Disease and Polycystic Ovary Syndrome in Adolescents: Pathogenesis, Prevalence, and Management Strategies
por: Półkośnik, Kinga, et al.
Publicado: (2023)

Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome
por: Shengir, Mohamed, et al.
Publicado: (2020)

OR15-3 Contribution of Hyperandrogenemia to Dysbiosis, Gut Inflammation, and Dysregulation of Short-Chain Fatty Acid Homeostasis in Mouse Model of Polycystic Ovary Syndrome
por: Alsemeh, Amira, et al.
Publicado: (2022)

The relationship between Polycystic ovary syndrome and vitamin D levels
por: Yılmaz, Setenay Arzu, et al.
Publicado: (2015)

An Update on Contraception in Polycystic Ovary Syndrome
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

Low Serum 25-Hydroxyvitamin D Levels Are Associated With Hyperandrogenemia in Polycystic Ovary Syndrome: A Cross-Sectional Study
por: Shan, Chang, et al.
Publicado: (2022)

Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation
por: Hai, Yang, et al.
Publicado: (2023)

Prevalence, Risk Factors, and Pathophysiology of Nonalcoholic Fatty Liver Disease (NAFLD) in Women with Polycystic Ovary Syndrome (PCOS)
por: Spremović Rađenović, Svetlana, et al.
Publicado: (2022)

Determination of insulin resistance and its relationship with hyperandrogenemia,anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome
por: YETİM ŞAHİN, Aylin, et al.
Publicado: (2019)

Cannabinoid Receptor 1 Gene Polymorphisms and Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome and in Healthy Controls
por: Kuliczkowska Plaksej, Justyna, et al.
Publicado: (2014)

Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia—A New Insight on Syndrome Pathogenesis
por: Ozegowska, Katarzyna, et al.
Publicado: (2020)

A Review of Special Considerations on Insulin Resistance Induced Hyperandrogenemia in Women with Polycystic Ovary Syndrome: A Prominent COVID-19 Risk Factor
por: Roozbeh, Jamshid, et al.
Publicado: (2022)

Polycystic Ovary Syndrome in Adolescence
por: Deans, Rebecca
Publicado: (2019)

Sensitive and specific markers for insulin resistance, hyperandrogenemia, and inappropriate gonadotrophin secretion in women with polycystic ovary syndrome: a case-control study from Bahrain
por: Golbahar, Jamal, et al.
Publicado: (2012)

Non-alcoholic fatty liver disease in polycystic ovary syndrome women
por: Won, Young Bin, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center
por: Taranto, Daniela Oliveira de Lima, et al.
Publicado: (2020)

Polycystic ovary syndrome is associated with nonalcoholic steatohepatitis in women of reproductive age
por: Maldonado, Stephanie S., et al.
Publicado: (2022)

Features of Polycystic Ovary Syndrome in adolescence
por: Tsikouras, P, et al.
Publicado: (2015)

Assessment of oral manifestations in pediatric patients with celiac disease in relation to marsh types
por: Elbek-Cubukcu, Cigdem, et al.
Publicado: (2023)

Abdominal Obesity as a Predictive Factor of Nonalcoholic Fatty Liver Disease Assessed by Ultrasonography and Transient Elastography in Polycystic Ovary Syndrome and Healthy Women
por: Tantanavipas, Siriluk, et al.
Publicado: (2019)

Could semiquantitative analysis of real-time ultrasound elastography distinguish more liver parenchyma alterations of nonalcoholic fatty liver disease in patients with polycystic ovary syndrome?
por: Di, Na, et al.
Publicado: (2019)

The Burden of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome: A Case–Control Study
por: Giannouli, Aikaterini, et al.
Publicado: (2023)

Predictivity of fatty liver index for non-alcoholic fatty liver disease in lean females with polycystic ovary syndrome
por: Arıkan, Didem, et al.
Publicado: (2022)

Metabolic effects of polycystic ovary syndrome in adolescents
por: Han, Yejin, et al.
Publicado: (2015)

11-Oxyandrogens in Adolescents With Polycystic Ovary Syndrome
por: Taylor, Anya E, et al.
Publicado: (2022)

An overview of polycystic ovary syndrome in aging women
por: Çelik, Özlem, et al.
Publicado: (2021)

Diagnosis of Sertoli-Leydig Cell Tumor of the Ovary Complicated by the Pattern of Hyperandrogenemia and Results of Imaging
por: Jaju, Amruta, et al.
Publicado: (2021)

Key Genes Associated With Non-Alcoholic Fatty Liver Disease and Polycystic Ovary Syndrome
por: Chen, Yong, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome
por: Hong, So-hyeon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b94btk1qvfka50463084ae75ho